Top
Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
Free Shipping On Orders Over $35!
Get Rewarded for Ordering Your Textbooks! Enroll Now
Customer Reviews Read Reviews
Write a Review
What is included with this book?
| Preface | |
| Introduction | |
| Economic development | |
| Systems analysis | |
| Contextual Factors Which Influence a National Pharmaceutical System | |
| The actors in the pharmaceutical systems | |
| Health care professional groups | |
| Drug producers | |
| Drug control | |
| Patients and their organizations | |
| Evaluations | |
| Deciding about the aim of the evaluation | |
| The identification of the system and its goals | |
| The identification of the evaluation dimensions and the decision on how to measure these dimensions | |
| The collection of data | |
| The summary of the results and the formulation of conclusions | |
| Social constructionism and social representation theory | |
| The actor-spectator paradox | |
| The decision-making processes in the drug system | |
| How attitudes and beliefs change - the balance model | |
| Summary of the chapter | |
| References | |
| A historical perspective of drug research and diffusion | |
| The period of folk medicine | |
| The merchant period (1500 AD to the end of the eighteenth century) | |
| The chemical period (the nineteenth century) | |
| The animal testing period (from 1900 to the end of the 1930s) | |
| The drug innovation period (from 1940 to 1964) | |
| The post-Thalidomide period (1965 to present) | |
| Future perspectives | |
| Summary of the chapter | |
| References | |
| National drug policies | |
| Efficient organization of drug support | |
| Efficient organization of drug research | |
| Efficient organization of drug production | |
| Efficient organization of drug distribution | |
| An efficient system for drug consumption | |
| An efficient system of drug information | |
| Choice of drugs with high therapeutic powers | |
| Choice of drugs with few side effects | |
| Low drug costs | |
| How to develop and implement a national policy | |
| Summary of the chapter | |
| References | |
| Planning the drug support | |
| Patent and exclusivity policies | |
| Trade name policy vs. generic name policy | |
| Generic and therapeutic substitution | |
| Generic prescribing | |
| Drug registration | |
| Drug reimbursement policies/national health insurance systems | |
| The public and private drug sectors of developing countries | |
| The primary health care policy | |
| The essential drugs policy | |
| Summary of the chapter | |
| References | |
| Drug research | |
| Drug company strategies | |
| Drug companies focusing on research to find new chemical substances intended for the international market | |
| Drug companies concentrating on efficient drug chemical production (bulk production) | |
| Companies concentrating on the marketing of non-patented ready-made drugs (generic production) | |
| Drug companies concentrating on the marketing of drugs for self-medication | |
| Drug companies concentrating on the sales of herbal medicines | |
| Factors which determine the resources a drug company spends on R&D | |
| The selection of research areas by a drug company | |
| The research process | |
| The project decision | |
| The research administration after a project has been accepted | |
| Research productivity | |
| Ethical concerns in drug research | |
| Summary of the chapter | |
| References | |
| Drug production.#60 | |
| Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Need Help? Copyright © 1999-2024